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It is generally unknown to what extent organ transplant recipients can be physically chal-
lenged. During an expedition to Mount Kilimanjaro, the tolerance for strenuous physical
activity and high-altitude of organ transplant recipients after various types of transplantation
was compared to non-transplanted controls.
Methods
Twelve organ transplant recipients were selected to participate (2 heart-, 2 lung-, 2 kidney-,
4 liver-, 1 allogeneic stem cell- and 1 small bowel-transplantation). Controls comprised the
members of the medical team and accompanying family members (n = 14). During the
climb, cardiopulmonary parameters and symptoms of acute mountain sickness were
recorded twice daily. Capillary blood analyses were performed three times during the climb
and once following return.
Results
Eleven of the transplant participants and all controls began the final ascent from 4700
meters and reached over 5000 meters. Eight transplant participants (73%) and thirteen con-
trols (93%) reached the summit (5895m). Cardiopulmonary parameters and altitude sick-
ness scores demonstrated no differences between transplant participants and controls.
Signs of hyperventilation were more pronounced in transplant participants and adaptation
to high-altitude was less effective, which was related to a decreased renal function. This
resulted in reduced metabolic compensation.
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Conclusion
Overall, tolerance to strenuous physical activity and feasibility of a high-altitude expedition
in carefully selected organ transplant recipients is comparable to non-transplanted controls.
Introduction
With the increased focus on long-term survival after organ transplantation, new questions are
emerging regarding physical possibilities and potential boundaries or limitations following
organ transplantation. Are physically demanding goals equally feasible for organ transplant
recipients (OTR) as they are for the non-transplanted population? The reported levels of physi-
cal activity (PA) are lower in OTR than that of the non-transplanted population [1–6] even
though organ functioning post-transplantation is nearly normal [7]. Furthermore, maximal
oxygen consumption is demonstrated to be significantly reduced with kidney and liver-tx
recipients and lung and heart-tx recipients, respectively reaching 65–80% and 50–60% of pre-
dicted [7]. These data suggest that strenuous PA, especially in an exceptional environment,
would not be feasible for OTR.
However, carefully selected and prepared liver transplant recipients appear to be equally tol-
erant to PA in, and exposure to, high-altitude as healthy controls [8]. So far, it is unknown if
recipients of other types of organ transplantation are equally tolerant to PA and exposure to
high-altitude. Hence, a transplant recipients' initiative to climb Mount Kilimanjaro was subse-
quently embraced by the Groningen Transplant Center. In addition to increasing awareness of
physical abilities after transplantation when a healthy lifestyle is adhered to and increasing
donor awareness, the aforementioned questions were studied during the expedition. The aims
of the present study are to evaluate the physical response, incidence of acute mountain sickness,
and tolerance to strenuous PA at heights above 5000 meters for various OTR compared to
non-transplanted controls. Based on the presented results in liver transplant recipients and our
clinical experience we hypothesize that well prepared OTR will not clinically differ from the
non-transplanted controls.
Materials and Methods
Study design and participants
A prospective cohort study was performed in which OTR were compared to non-transplanted
controls during the preparation and expedition to the summit of Mount Kilimanjaro (5895m),
Tanzania. The selection of OTR occurred in March and April 2014. Possible participants were
preselected by their treating physician. To be considered as eligible, OTR had to be at least 12
months post-transplantation, have a stable cardiopulmonary status, and have no signs of acute
or chronic rejection in the previous 12 months. Furthermore, OTR were required to be between
18 and 60 years of age and have a normal to active lifestyle. Exclusion criteria were renal dys-
function (creatinine clearance< 40ml/min.) and insulin dependent diabetes mellitus. The
selection of OTR occurred following cardio pulmonary exercise testing (CPET), peripheral
muscle strength testing, and an intake interview. The interview was directed at obtaining
insight into the motivation to participate, the coping style of the participant, and the experience
and expectations with camping in harsh conditions. As a control group we used a convenience
sample consisting of the members of the medical team and family members that accompanied
the expedition. All participants signed informed consent. The study complied with the
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declarations of Helsinki and Istanbul, and the Institutional Review Board of the University
Medical Center Groningen provided approval to conduct the study (M14.162650).
Cardio pulmonary exercise testing (CPET)
CPET was performed on a stationary electromagnetically braked cycle ergometer (Lode, Gro-
ningen, the Netherlands) according to the international guidelines [9]. The rate of progressive
increase in workload was adjusted to the (estimated) fitness level of the participant (15–30
Watt). Breath by breath analysis using flow and inspiratory and expiratory gas fractions at the
mouth was used to calculate all ventilatory variables (CareFusion, Master Screen CPX, Ger-
many). The ventilatory and anaerobic thresholds were determined by V-slope (VE/VCO2) and
increments in O2 equivalent. Heart rate was registered with a 12-point electrocardiography
(KISS 10, GE Medical Systems), blood pressure was monitored every two to three minutes by
manual measurement (sphygmomanometer and stethoscope), and the achieved maximal load
was recorded. A systolic blood pressure of 250 mmHg and a diastolic blood pressure of 130
mmHg were indications for termination of the exercise test.
The estimated metabolic equivalent (MET, one MET = 3.5 ml/kg/min) needed for hiking
(steep grade with 5-18kg pack) is 7.3 MET’s [10]. This MET value was used to calculate the
equivalent VO2max value by multiplying it by 3.5 [11]. This resulted in a estimated required
VO2 value of 25.6 ml/kg/min. Based on this value the minimal (age and gender adjusted) crite-
rion for maximal oxygen consumption (VO2max) was established at the level ‘fair/good’
according to the American College of Sports Medicine [11].
Peripheral muscle strength
Maximal voluntary isometric strength of the quadriceps muscles was measured utilizing a
hand-held dynamometer (MicroFET II™, Hoggan Health Industries, UT, USA). Isometric
handgrip strength was determined with a Jamar hand dynamometer (Lafayette Instrument
Company, USA). Measurements were performed three times for each muscle group in testing
positions described earlier [12,13]. The mean measured peak force in Newton of the dominant
side of the participant was used for further analysis and compared to calculated predicted val-
ues [14,15].
Selection
A total of twelve OTR were selected to participate (2 heart-, 2 lung-, 2 kidney-, 4 liver-, 1 alloge-
neic stem cell- and 1 small bowel-transplantation). None of the selected OTR had prior high-
altitude mountaineering experience. The convenience control group consisted of 14 partici-
pants of whom eight were members of the medical team. All members of the medical team per-
formed an exercise test to assure adequate exercise capacity to get along with the group and
provide support where necessary.
Preparation
Following selection, the transplant participants began an individual training schedule based on
the results of the CPET and peripheral muscle strength testing. Training zones were deter-
mined, and a schedule was composed with a minimum of three training sessions per week.
Depending on the test results, the focus was adjusted towards cardio or strength training and
initiated six months prior to departure. Additionally, three central training sessions were orga-
nized whereby transplant participants and members of the medical team walked distances up
to 20 kilometers which also allowed for all to become acquainted with each other.
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All participants were vaccinated according to the current recommendations and received
malaria prophylaxis. Beginning one day prior to the climb up until reaching the summit, all
participants received a prophylactic dose of acetazolamide (125 mg twice daily) to prevent
acute mountain sickness. One Tx-participant and one control used a homeopathic agent
instead of acetazolamide. Furthermore, a fluid intake of four to five liters per day was recom-
mended to all participants. All transplant participants continued their own immunosuppres-
sant medication regimen.
Daily measurements
All measurements were performed twice daily (AM and PM) and consisted of the measure-
ment of blood pressure (manually); oxygen saturation; heart frequency (Pulse oximetry, Con-
tec CM550D, Contec Medical System Co, LTD, China); and symptoms of altitude sickness.
Symptoms of altitude sickness were monitored using the Lake Louise Acute Mountain Sickness
Scores [16]. Hereby, scores on a four point scale (0–3) were assigned to: ‘headache’; ‘gastroin-
testinal complaints’; ‘fatigue and/or weakness’; ‘dizziness and/or lightheadedness’; and ‘diffi-
culty sleeping’. Additionally, Borg scores for the rate of perceived exertion (6–20; 20 = maximal
exertion) were registered [17]. Daily measurements were not performed on the morning of the
summit attempt because of lack of time due to departure at midnight. No measurements were
performed at the summit because staying at the summit longer than needed is discouraged
because of an increasing risk of acute mountain sickness.
Capillary blood analysis
Capillary blood was analyzed on day 0 (1000m), day 5 (4030m), day 9 (1400m), and six weeks
following the expedition (sea level) with a handheld analysis system (i-Stat1 system, Abbott
Point of Care Inc., Princeton, NJ, USA). Calibration to the barometric pressure was performed
at each altitude before measurements. Analyses were performed utilizing CG4+ cartridges,
which use a blood sample of 95μL. Data was generated on pH (hydrogen ion concentration),
pCO2 (carbon dioxide pressure, kPa), pO2 (oxygen pressure, kPa), bicarbonate (HCO3
-,
mmol/L), Base Excess (metabolic component compensating pH deviations, mmol/L), saO2
(oxygen saturation, %), and lactate (mmol/L).
Route
Participants entered the National Park via the Londorossi gate and began walking at 3400
meters. The ascent to the summit of Mount Kilimanjaro (5895m) was made in seven days. On
the seventh day, the descent was made to 3810 meters followed by further descent to Mweka
Gate (1640m) on the eighth day (Table 1). A distance of approximately 60 kilometers was
covered.
Statistical methods
Baseline characteristics were analyzed with descriptive statistics. Univariate comparison
between groups was performed with an independent t-test or Chi-square. In the event of a
non-normal distribution, a Mann-Whitney- U or Fisher’s exact test was used. For categorical
data, proportions are shown. To analyze change over time in oxygen saturation, heart fre-
quency, blood pressure, and LLAMS scores and to account for intra-recipient’s correlations
between repeated measures, a Linear Mixed Model (LMM) analysis was performed. A
Restricted Maximum Likelihood Method and unstructured correlation structures were used.
‘Altitude’ and ‘AM/PMmeasurement’ were set as factors. Potential explanatory variables
Physical Activity in Organ Transplant Recipients
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(including age, gender, BMI, and category [Tx vs. Control]) were entered into the LMM (fixed
effects). The variables ‘Age’ and ‘BMI’ were centered to the means of the study population to
increase clinical interpretability [18]. Additional LMM analyses were performed for all capil-
lary blood gas values with ‘altitude’ as factor and ‘age’, ‘gender’, and ‘Tx vs. control’ as potential
explanatory variables. Analyses were performed with the statistical programming language R,
version 2.12.0 and IBM SPSS statistical software, version 20.0. A p-value< .05 was considered
statistically significant.
Results
Baseline characteristics of the transplant participants and controls (Tables 2 and 3) did not sig-
nificantly vary for age (p = .186), gender (p = .716), BMI (p = .089), VO2max (p = .521), and
peak load (p = .351).
Cardiopulmonary response
With increasing altitude, a similar decrease in oxygen saturation was seen in the transplant par-
ticipants and the control group (Fig 1A). Results of the LMM showed that transplant partici-
pants did not have significantly different saturation levels. Factors that significantly
contributed to decreasing saturation levels were increasing age and increasing altitude. PM sat-
urations were significantly lower than AM saturations (Table 4).
The course of heart frequency showed a gradual increase (and decrease) along with the
increase (and decrease) of altitude (Fig 1B). The LMM showed no significant difference
between transplant participants and controls. Heart frequency was significantly influenced by
gender (female>male) and altitude. PM heart frequency was lower than AM heart frequency
(borderline significance, p = .045, Table 4).
Analysis of blood pressure indicated that systolic blood pressure (SBP) initially increased in
all subjects followed by a minimal decrease in the second half of the climb. Diastolic blood
pressure (DBP) showed a comparable pattern, however, where transplant participants showed
relatively stable values, the control group demonstrated a more fluctuating course (Fig 1C). No
significant differences were found between the transplant participants and the controls for SBP
and DBP. Factors that did significantly influence SBP and DBP were altitude and time of day;
Table 1. Route and altitudes.
Day Departure Arrival
-1 Schiphol Airport 0 Arusha 1400
0 Arusha 1400 Arusha 1400
1 Londorossi Gate 2360 Start walking 3400 Shira 1 3505
2 Shira 1 3505 Shira 2 3810
3 Shira 2 3810 Lava Tower* 4630 Barranco 3980
4 Barranco 3980 Barranco Wall 4230 Karanga 4030
5 Rest day Karanga 4030 Karanga 4030
6 Karanga 4030 Barafu 4680
7 Barafu 4680 Uhuru Peak 5895 Millenium camp 3815
8 Millenium camp 3815 Mweka Gate 1640
* Eight Tx-participants and ten controls traveled the route over Lavatower. The remaining participants ascended to 4400 meters and, from there, took the
lower route to Barranco camp.
doi:10.1371/journal.pone.0142641.t001
Physical Activity in Organ Transplant Recipients
PLOS ONE | DOI:10.1371/journal.pone.0142641 November 25, 2015 5 / 13
PM SBP and DBP values were significantly higher than AM values (Table 4). One transplant
participant and one control experienced high blood pressure (DBP> 115 mmHg) for which
they received nifedipine.























1 Lung IPF 19 M 56 22.5 210 36.8 Good 84 88
2 Lung PAH 7 F 44 24.1 220 32.7 Good 111 113
3 Heart Cong. AV-block 3 F 22 21.8 198 35.0 Good 65 133
4 Heart HCM 4 F 57 22.7 175 28.0 Good 94 104
5 Kidney, test 1 IgA nephropathy 1 M 35 25.0 215 27.6 - 85 116
test 2± 25.0 240 42.5 Good - -
6 Kidney IgA nephropathy 2 F 28 29.8 212 30.1 Fair 58 109
7 Liver Tyrosinemia type 1 22 M 23 24.0 280 45.2 Good 79 129
8 Liver PSC 6 F 52 22.1 148 36.9 Excellent 75 108
9 Liver PSC 2 M 44 25.3 308 36.6 Fair 102 83
10 Liver, test 1 PSC 3 M 43 24.1 248 27.7 - 77 94
test 2+ 22.9 300 39.0 Good - -
11 Stem cell CML 8 M 31 24.4 305 44.4 Good 71 98
12 Small-bowel Bowel resection after
thrombosis
2 F 54 24.3 134 26.8 Fair 81 91
Median 3.5 6M/ 6F 43.5 24.1 212 36.7 - 80 106
IQR 2.0–7.75 28.8–53.5 22.6–25.1 175–300 30.8–41.6 - 72–92 92–115
± Second test due to abortion of Test 1 due to high blood pressure; the second test was an Astrand cycle ergometer test.
+ Second test due to insufﬁcient performance for Test 1; Test 2 performed ten weeks after Test 1. IQR: inter quartile range. IPF: idiopathic pulmonary
ﬁbrosis, PAH: pulmonary arterial hypertension, HCM: hypertrophic cardiomyopathy, PSC: primary sclerosing cholangitis, CML: chronic myeloid leukemia.
Tx: transplantation.
*1Time since Tx in years on date of departure to Tanzania.
*2 CPET criterion: cardio pulmonary exercise testing, criterion according to the American College of Sports Medicine [11].
doi:10.1371/journal.pone.0142641.t002
Table 3. Baseline characteristics control group.
Control nr. Gender (M/F) Age (years) BMI (kg/m2) Peak load (W) VO2max (ml/min/kg) CPET criterion*
1 M 31 21.9 371 50.3 Excellent
2 M 52 24.0 374 45.7 Excellent
3 M 49 24.9 295 39.5 Good
4 F 51 29.7 170 23.9 Fair
5 F 32 28.7 280 36.1 Very good
6 F 52 24.1 256 38.9 Excellent
7 F 19 21.4 245 37.4 Good
8 F 56 24.3 166 30.5 Good
9 M 46 24.9 NA NA NA
10 M 24 25.8 NA NA NA
11 F 60 24.5 NA NA NA
12 F 42 23.3 NA NA NA
13 F 31 22.8 NA NA NA
14 M 50 24.7 NA NA NA
Median 6M/ 8F 47.5 24.5 268 38.2 -
IQR 31.0–52.0 23.5–25.6 189–352 31.9–44.2 -
IQR: inter quartile range.
*CPET criterion: cardio pulmonary exercise testing; criterion according to the American College of Sports Medicine [11]. NA: not applicable.
doi:10.1371/journal.pone.0142641.t003
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Fig 1. Course of saturation (a), heart frequency (b), and systolic and diastolic blood pressure (c) during the expedition.
doi:10.1371/journal.pone.0142641.g001
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Altitude sickness scores
Altitude sickness scores on the LLAMS questionnaire increased gradually with the increase in
altitude. LMM analysis showed that LLAMS scores were significantly higher than values at sea
level for all measurements between 1640 and 3900 meters (p =< .001 to .015). No significant
differences in altitude sickness scores were determined between transplant participants and
controls (p = .916). However, one of the returning transplant participants exhibited symptoms
of hypothermia and/or altitude sickness whereas no participant in the control group displayed
symptoms of such severity that it limited the summit attempt. The analysis showed an addi-
tional significant difference in LLAMS scores between male and female (β = 0.6, p = .007) indi-
cating higher LLAMS scores in female participants. Borg scores for perceived exertion did not
significantly differ between transplant participants (median (interquartile range (IQR))) 6 (6–
9) and controls 6 (6–9), p = .983.
Capillary blood values
Change over time in pH was minimal, and median (IQR) pH was 7.39 (7.37–7.41). Levels of
pCO2, base excess, and bicarbonate were decreased at 4030m compared to values at 1000m,
increased slightly returning to 1400m, and returned to normal at 0m. Levels of pO2 were
decreased at 4030m compared to values at 1000m and returned to normal at 1400m and 0m.
Lactate levels were the lowest at 1000m (median (IQR) 1.1 (0.9–1.4)), levels increased at
4030m, and increased further upon return to 1400m (measurement after two long days of
walking). Lactate levels at 0m were lower than levels at 4030 and 1400 meters, but turned out
to be higher than levels measured at 1000m. Saturation levels followed the same previously
described pattern (Fig 1A). Absolute values per measuring moment are illustrated in Table 5.
The LMM analysis of capillary blood values ascertained no significant differences between
Table 4. Results linear mixedmodel on factors predicting change in saturation, heart frequency, systolic and diastolic blood pressure.
Saturation Heart Frequency SBP DBP
Parameter β 95% CI p-value β 95% CI p-value β 95% CI p-value β 95% CI p-value
Intercept 97.4 96.1; 98.7 < .001 75.6 68.3; 82.8 < .001 138.5 128.4; 148.5 < .001 84.5 77.3; 91.6 < .001
Age -0.1 -0.1; -0.0 .010 -0.03 -0.3; 0.2 .808 0.4 -0.0; 0.8 .064 0.2 -0.1; 0.5 .270
Gender (female) 0.6 -0.7; 1.8 .347 10.9 2.9; 19.0 .010 -2.6 -13.9; 8.7 .641 3.3 -4.9; 11.5 .414
BMI -0.02 -0.07; 0.04 .528 0.1 -0.2; 0.5 .484 0.1 -0.4; 0.6 .748 0.2 -0.1; 0.5 .208
Altitude
0 m. Ref Ref Ref Ref
1000 m. 0.7 -0.2; 1.7 .125 -3.0 -6.7; 0.8 .124 -6.1 -11.1; -1.2 .016 -4.2 -7.2; -1.2 .006
1400 m. 0.3 -0.8; 4.5 .571 -3.0 -7.7; 1.7 .213 -12.3 -18.6;-6.0 < .001 -8.5 -12.3; -4.7 < .001
1640 m. -0.2 -1.4; 1.1 .802 -0.5 -5.5; 4.5 .842 -20.2 -26.9;-13.6 < .001 -10.4 -14.4; -6.4 < .001
3515 m. -3.9 -4.9; -2.9 < .001 6.8 2.7; 10.9 .001 2.2 -3.3; 7.6 .429 3.4 0.1; 6.7 .043
3900 m. -5.9 -6.8; -5.0 < .001 7.7 4.1; 11.2 < .001 -2.5 -7.2; 2.2 .302 -1.7 -4.6; 1.1 .224
4680 m. -9.7 -11.0; -8.5 < .001 18.4 13.4; 23.4 < .001 -11.1 -17.7; -4.5 .001 -7.6 -11.6; -3.7 < .001
Time day (PM) -0.8 -1.3; -0.4 < .001 -1.7 -3.3; -0.0 .045 5.0 2.8; 7.2 < .001 4.4 3.1; 5.7 < .001
Tx vs. control -0.1 -1.2; 0.9 .786 3.1 -4.0; 10.2 .372 3.0 -7.0; 13.0 .543 4.7 -2.7; 12.0 .205
SBP: systolic blood pressure, DBP: diastolic blood pressure, Tx: transplant. Total N = 26 (Tx-group n = 12 + control group n = 14). Age centered at 42 and
BMI at 24 (means study population). The reported β represents the difference in the outcome variable compared to the reference category (categorical
data) or the expected change in the outcome variable with one unit change of that parameter (continuous data). Example: saturation is expected to be
9.7% less at an altitude of 4680 meters and, with every year that someone is older a decrease in saturation of 0.1% is expected.
doi:10.1371/journal.pone.0142641.t004
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transplant participants and controls for pH (p = .073), pO2 (p = .118), saO2 (p = .485), and lac-
tate (p = .548). However, significant between group differences were observed for pCO2 (β =
0.4, CI = 0.2;0.7, p = .003), bicarbonate (β = 2.5, CI = 0.8; 4.1, p = .006) and Base Excess (β =
2.6, CI = 0.8; 4.3, p = .008) for which transplant participants exhibited lower values compared
to controls. Furthermore, all capillary blood values were significantly and negatively influenced
by altitude (versus sea level): pH [4030m]; pCO2 and BE [1400m, 4030m]; pO2 and HCO3
-
[1000m, 1400m, 4030m]; saO2 [1000m, 4030m]; and Lactate [1000m]).
Success rate
Eleven of the 12 transplant participants and all of the controls climbed above 5000 meters. One
transplant participant returned at an early stage (day 4) due to the harsh circumstances. On the
day of the summit attempt, one transplant participant could not maintain the required pace
and one transplant participant needed to return prematurely due to not being fully recovered
from a gastroenteritis two days before. Whether the last returning transplant participant had
experienced acute mountain sickness, hypothermia, or both could not be determined with cer-
tainty. The three participants that had to return during the summit attempt all had a good to
excellent exercise capacity at baseline. The remaining eight transplant participants reached
Uhuru peak at 5895 meters. Out of the control group, all but one reached the summit. One
member of the medical team accompanied the returning transplant participants. All partici-
pants reaching the summit are pictured in Fig 2.
Discussion
The results from this study indicate that OTR that are physically fit and well prepared are
equally capable of making a summit attempt on Mount Kilimanjaro compared to non-trans-
planted controls. First, saturation, heart frequency, and blood pressure did not differ between
transplant participants and controls. Second, even though every participant experienced some
symptoms of acute mountain sickness, established mountain sickness did not occur, and scores
on the LLAMS questionnaire did not differ between transplant participants and controls.
Finally, the tolerance to strenuous physical activity at high altitude in transplant participants
appeared to be no different than that of comparable controls, confirming our hypothesis. Fur-
thermore, no indications of rejection or infection related to this expedition have occurred.
As expected, both groups hyperventilated to compensate for high-altitude induced hypox-
emia. However, more pronounced signs of hyperventilation occurred in transplant participants
as indicated by the lower pCO2. The adaptation to high-altitude was less effective in transplant
Table 5. Median (IQR) capillary blood gas values per altitude for Tx-participants and controls.
0 meters 1000 meters 4030 meters 1400 meters
Tx-participants Controls Tx-participants Controls Tx-participants Controls Tx-participants Controls
pH 7.40 (7.38; 7.40) 7.40 (7.38; 7.41) 7.40 (7.37; 7.40) 7.38 (7.37; 7.40) 7.36 (7.32; 7.42) 7.39 (7.37; 7.41) 7.36 (7.31; 7.41) 7.42 (7.38; 7.42)
pCO2 5.21 (4.96; 5.49) 5.54 (5.05; 5.78) 4.83(4.64; 5.12) 5.43 (5.36; 5.60) 3.62 (3.24; 4.01) 3.75 (3.57; 4.00) 3.84 (3.51; 4.09) 4.45 (4.17; 4.56)
pO2 10.1 (8.8; 11.1) 9.5 (8.9; 10.1) 8.5 (8.1; 9.1) 7.8 (7.6; 8.5) 5.7 (5.2; 6.4) 5.6 (4.8; 6.0) 9.0 (8.1; 9.5) 8.6 (8.5; 9.0)
HCO3- 23.5 (22.4; 25.3) 25.3 (23.3; 27.6) 22.5 (20.7; 23.5) 24.2 (23.6; 25.5) 16.0 (13.4; 17.7) 16.2 (15.8; 18.8) 17.2 (13.6; 19.0) 20.2 (19.4; 21.5)
Base Excess -1 (-3; 0) 0 (-2; 3) -2 (-4; -1) -1 (-1; 1) -8 (-11; -5) -7 (-8; -5) -8 (-11; -5) -4 (-4; -3)
SaO2 96 (92; 96) 94 (93–95) 92 (91; 94) 90 (89; 92) 79 (73; 82) 78 (68; 82) 92 (90; 94) 93 (92; 93)
Lactate 1.33 (1.14; 1.74) 1.75 (1.26; 2.12) 0.95 (0.88; 1.15) 1.36 (0.99; 1.43) 1.64 (1.37; 1.85) 1.70 (1.25; 1.89) 1.71 (1.29; 2.30) 1.40 (1.07; 2.33)
pCO2: carbon dioxide pressure, kPa. pO2: oxygen pressure, kPa. HCO3
-: bicarbonate, mmol/L, Base Excess: metabolic component compensating pH
deviations, mmol/L. saO2: oxygen saturation, %. Lactate in mmol/L.
doi:10.1371/journal.pone.0142641.t005
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participants than that of the control group as reflected by the lower bicarbonate in transplant
participants. This resulted in reduced metabolic compensation. We hypothesize that this is due
to the reduced renal function of the transplant participants (estimated creatinine clearance was
reduced to a median of 67 ml/min/1.73m2; data not shown). The differences between groups at
4030 meters were more moderate and most likely mitigated by the use of acetazolamide at this
altitude (in both groups). Acetazolamide inhibits carbonic anhydrase resulting in a loss of
bicarbonate. The equivalent levels of bicarbonate at 4030 meters could possibly be explained by
the impact of acetazolamide being less in subjects with impaired renal function. Differences in
absolute capillary blood values, however, were minimal, therefore, clinical significance is pre-
sumably limited. The results do indicate that at least a moderate renal function is a prerequisite
for a high-altitude expedition.
Although Mount Kilimanjaro is perceived as an easily accessible trekking peak that can be
climbed with minimal climbing experience or technical skills, the reported success rates of 61%
to 77% in the general tourist population combined with a reported oxygen level at the summit
Fig 2. Transplant recipients andmedical team at the summit of Mount Kilimanjaro.Consent to publication was obtained from all participants.
doi:10.1371/journal.pone.0142641.g002
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comparable to 10.1% at sea level indicates that climbing Mount Kilimanjaro requires strenuous
performance [19,20]. Hypoxia, (symptoms of) acute mountain sickness, low temperatures,
basic accommodation, and poor hygienic circumstances challenge the body and possibly, even
more importantly, the mind. The 67% success rate in the group of transplant recipients of the
current study is comparable to the success rate of the tourist population. This summit success
rate, however, was lower than the reported success rate of 83% (5 out of 6) in the expedition
with liver transplant recipients [8]. A possible explanation for the higher success rate in the
group of liver transplant recipients could possibly be that all transplant participants in that
expedition received dexamethasone prior to the summit attempt. Although the success rate of
the transplant participants in the current study differed from this success rate and the success
rate of our control group, reasons for abandoning the summit attempt were not clearly related
to having had an organ transplant. The exercise capacity of the three recipients that had to
abort the summit attempt was good to excellent at baseline. Therefore, it seems that pre-expe-
dition exercise capacity alone is not a strong predictor of a successful summit attempt.
However, the results of the present study do not suggest that this type of expedition is a fea-
sible undertaking for all OTR. The generalizability of results is limited due to the fact that the
transplant participants in the current study represent a well-selected and prepared group that
was accompanied by a medical team. Our recommendation to those willing to undertake a sim-
ilar extreme expedition would be to have an extensive medical examination including maximal
exercise testing, become physically and mentally well prepared. Furthermore, people should
get informed on adequate hydration, the need to follow-up the advise of the trained guides to
descend when AMS is suspected, and take hygienic precautions. In the current expedition, pre-
cautions were taken to optimize hygienic circumstances by instructing the cooking staff to boil
or heat all food sufficiently, using hand sanitizer frequently, using bottled water for transplant
participants in the lower regions (with higher risk of contamination), and using boiled and
purified water only at the highest altitudes. As the most important prophylactic strategy to
avoid acute mountain sickness is a slow rate of ascent [21], a route and schedule providing suf-
ficient time to acclimatize is considered mandatory.
The limited sample size that is inherent to an expedition of this type makes overall gener-
alizability moderate to low. The group of transplant participants consisted of persons with a
variety of organs transplanted, which shows the possibility of climbing mount Kilimanjaro
after various transplantation types but renders limited general conclusions per group. Further-
more, the study is limited by the fact that the control group was not matched to the transplant
participants, as a convenience control group was used. However, comparison of both groups
before the expedition on relevant parameters did not reveal any statistical significant or clini-
cally relevant between group differences and the control group is therefore seen as acceptable.
Conclusion
Although a high altitude expedition is considered extremely challenging this study demon-
strates that carefully prepared people after various types of organ transplantation can perform
strenuous physical activity at high-altitude. Their tolerance to physical activity at high-altitude
showed to be good and comparable to non-transplanted controls. This confirms what was pre-
viously found in liver transplant recipients. A wonderful ‘side-effect’ was the incredible boost
in self-confidence for all of the transplant participants, accomplished due to the sheer fact that
they had been invited to participate and to reaching goals that they perceived to be out of reach
before. We hope this might provide an optimistic perspective for those awaiting an organ
transplant and also for people that have already received an organ transplant. Considerable
heights can be achieved with training, a good lifestyle, and incredible perseverance.
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